Host defense mechanisms against the opportunistic fungal pathogen Candida albicans have not been well defined. There are numerous reports of clinical observations relating various immune and endocrine dysfunctions with susceptibility to candidiasis, and controlled experiments have been done in animal models which simulate human candidiasis. Yet the literature is replete with conflicting data. Clinical observations have led to the general feeling that cellmediated immune function is a critical host defense against chronic mucocutaneous candidiasis (12) , but many individuals with chronic mucocutaneous candidiasis do not have detectable cell-mediated immune defects (36) and Tcell-deficient animals are not more susceptible to acute candidiasis (2, 29) . Because antibodies against C. albicans are commonly found in patients with various forms of candidiasis it has been held that the specific fungal antibodies are not protective, but indirect evidence that such antibodies may be protective has been obtained by using the mouse as an animal model (22, 24) . Numerous reports have shown that human neutrophils and macrophages can ingest and kill C. albicans (15, 16, 32) , but candidiasis is not necessarily a problem in individuals with defective phagocytic cells.
Classical methods have been used in most of the above studies. That is, in clinical observations a patient with candidiasis is assessed for immune dysfunctions and correlations are drawn. In the controlled experimental situation, various immune functions are either stimulated or suppressed, and then the animals are tested for susceptibility to a viable challenge of the fungus. These experimental protocols are designed primarily to ask what is the effect of various host defense mechanisms on C. albicans.
Recently, investigators have begun to ask what is the effect of C. albicans on host immunity. Suppressor T-cell activity was found in three offour patients who had relapse of a disseminated fungal, but not candidal, disease (34) . Enhanced specific antibody production has been observed in patients with chronic mucocutaneous candidiasis (35) . A polysaccharide from C. albicans has been reported to induce both human T-cell-dependent B-cell mitogenic responses and, surprisingly, B-cell-dependent T-cell mitogenic responses in vitro (25) . Cell walls of C.
albicans have also been found to enhance delayed-type hypersensitivity reactions to ovalbumin in guinea pigs (13) Mouse thyroglobulin was prepared as described elsewhere (8), with some exceptions, as follows. Thyroids were removed from mice and homogenized in ice-cold saline with a hand glass tissue grinder. The homogenate was centrifuged at 350 x g for 30 min, and the supernatant material was again centrifuged at 65,000 x g for 45 min. The thyroglobulin was precipitated with 45% saturated ammonium sulfate, solubilized in saline, and dialyzed against cold saline to remove residual ammonium sulfate. The solution of thyroglobulin was filter sterilized and stored at -20°C until use. The effect of C. albicans on induction of autoantibodies (i.e., anti-thyroglobulin) was determined by immunizing DBA/1J mice with 50 Fg of mouse thyroglobulin i.v. (N. Rose, personal communique) with or without adjuvant on days 0 and 7. In this experiment adjuvants consisted of whole cells or fractions of C. albicans given i.v. or i.p. or 20 ,ug of LPS. At 7-day intervals after the second injection, mice were bled and anti-thyroglobulin titers were determined in microtiter plates with SE coated (by the chromium chloride method) with thyroglobulin. Coating of SE with thyroglobulin was confirmed by reactivity with mouse serum which contained a known amount of anti-thyroglobulin (a generous gift from YiChi M. Kong and N. R. Rose).
Plaque-forming cell assay. Four or five days after immunization of mice, the number of spleen cells producing antibody specific to the antigen used for immunizing was determined by a slide modification of the localized hemolysis-in-gel technique (10, 20) . Depending on the immunizing antigen the indicator cells used to determine the number of specific PFC that were SE or SE coated with the appropriate antigen. In some experiments SE were coated with PVP by a tanning procedure (14) and used within 2 h after coating. PFC responses in mice sensitized to CGG or CGG-HE with or without C. albicans were assessed by using CGG-coated SE as described previously (18) . albicans polysaccharide (Ca-PS) was given i.p. at the time of inoculation of SE. One group of mice received 107 viable C. albicans i.p. 6 days before inoculation of 0.1 ml of 1% SE i.p. The cell wall preparation was from a glass bead breakage of whole cells as described previously (14) . PFC were determined 4 (Fig. 1) . Although similar results were obtained in BALB/c, DBA/1J, and SwissWebster mice, unless indicated otherwise the subsequent experiments were done on BALB/c animals. Also, immunopotentiation of comparable magnitude was induced by another strain of C. albicans (obtained from T. Mitchell, Duke University), three other species of Candida, and a strain of Saccharomyces cerevisiae. However, the remaining experiments were done on C. albicans strain 9938.
The immunopotentiation occurred when yeast cells were given at the time of injection of SE, but did not occur when injection of yeasts preceded the SE by 4 days. Mice preinjected with C. albicans still gave a heightened response to SE when a second injection of yeasts was given at the time of immunization with SE. Animals infected i.p. with viable yeasts 6 days before sensitization with SE also produced a heightened response to SE (Fig. 1) . Microscopic examination of spleen cell preparations from infected animals revealed numerous yeasts. Animals given either dead or viable C. albicans, but no SE, did not have higher than background SE-specific PFC per spleen. The responses appeared to be specific because mice injected with C. albicans and SE did not have higher than background numbers of HE-specific PFC per spleen (data not shown).
Immunopotentiation was not dependent on whole cells of C. albicans. Cell wall fractions of yeast cells and C. albicans polysaccharide also enhanced mouse responses to SE (Fig. 1 ). An adjuvant effect occurred also in mice injected i.p. with 100 jig of E. coli LPS instead of C.
albicans polysaccharide at the time of an i.p. injection of SE. From 2 to 4 times more SEspecific PFC per spleen were recovered from mice injected with LPS and SE than from mice injected with only SE.
C. albicans produced only a marginal effect when the fungus was given i.p. and the SE were given i.v. or when both materials were given i.v. (Table 1 statistically different in mice injected with PVP alone from mice injected with PVP and C. albicans. Responses ranged from 9,000 to 12,000 PFC per spleen when PVP alone or with the fungus was given i.v. and from 2,200 to 3,300 PFC per spleen when the antigen with or without C. albicans was given i.p. A slight enhancement of response to CGG occurred when the protein was given i.p. with C. albicans (Fig. 2) . However, when the CGG was coupled to HE, C. albicans-induced immunopotentiation of responses to CGG was much mbre remarkable.
Attempted induction of autoantibodies to thyroglobulin. An additional comparison was made between adjuvant activity of C. albicans and E. coli LPS by attempting to induce autoantibodies to thyroglobulin in DBA/1J (H-2q haplotype) mice. By 21 days after the sensitizing dose of antigen, mice injected i.v. with mouse thyroglobulin and 20 ,Ig of LPS developed an average anti-thyroglobulin passive hemagglutination log2 titer of 10 (range, 7 through 13). Mice injected with thyroglobulin alone had an average titer of 2.4 (range, 1 through 4); mice injected i.v. with thyroglobulin and 500 ,ug of C. albicans polysaccharide averaged 4.6 (range, 1 through 6); mice injected i.v. with thyroglobulin and 100 g of C.
albicans polysaccharide averaged 2.8 (range, 1 through 6); and mice injected i.p. with thyroglobulin and 107 C. albicans cells averaged 2.6 (range, 1 through 5). These data indicate that whereas LPS induces a high titer of autoantibodies to mouse thyroglobulin, the effects of C. albicans on this induction are minimal.
Effect of C. albicans on tissue distribution of SE. The poor potentiation or adjuvant activity of C. albicans when soluble antigens are used, when the fungus is given i.v., or when particulate antigen is given i.v. instead of i.p. may suggest that the immunopotentiation is not due to activation of cells such as macrophages or lymphocytes. Rather, coinjection of a particulate antigen and C. albicans at a local site may somehow influence the rate of presentation of antigen to the immune system. To test this idea In some cases the inoculum also contained 107 killed C. albicans yeasts. b At appropriate times post-inoculation mice were exsanguinated, and the indicated tissues were removed, rinsed several times in saline, blotted, weighed, and placed in vials for determination of counts per minute in a gamma counter. The numbers expressed represent means and standard deviations from an experiment involving four mice per group. Repeat experiments gave similar results.
c NS, Not significantly greater than background.
51Cr-labeled SE were injected i.p. alone or with C. albicans. At different times after the injection the distribution of SE in inguinal lymph nodes, mesenteric lymph nodes, spleen, and liver was determined. By 2 h postinjection the appearance of radiolabel in the lymph nodes and spleen was relatively unaffected by the presence of yeasts in the peritoneal cavity. The liver, however, contained more radiolabel when yeasts were injected i.p. along with the labeled SE ( Table 2) . By 6 h the amount of radiolabel appearing in the liver approached the amount of radiolabel trapped by the liver in 2 h after an i.v. injection of labeled SE. It is unlikely that the increase in counts associated with the liver is due to nonspecific adsorption of labeled SE on the organ surface because (i) all organs were vigorously rinsed twice in saline before counting, and (ii) a C. albicans-associated increase in radiolabel of other peritoneal organs did not occur. Because C. albicans activates the alternative complement cascade (21, 26) , enhancement of liver uptake of particulate antigen in the peritoneal cavity may be associated with induction of acute inflammation by the fungus. To test this idea, shellfish glycogen was used to determine its effect on liver uptake of 51Cr-labeled SE. By 2 h postinjection, animals which received a combination of labeled SE and glycogen had 3 to 4 times more radiolabel in their liver than did animals which received only SE (data not shown).
An association of inflammation (and rapid uptake of antigen by the liver) with enhanced immune responsiveness was further demonstrated by examining the effect of glycogen on immune responsiveness of mice to SE. Mice injected i.p. with SE and glycogen developed more SE-specific PFC per spleen than did mice injected i.p. with SE alone (Table 3) .
It may be expected that products of an acute inflammatory response will lead to lysis of SE. Such lysis, however, is either not important or not in itself sufficient to explain the immunopotentiation because mice responded poorly to an i.p. injection of lysed SE (Table 3 ).
DISCUSSION
We demonstrated that C. albicans can induce an enhanced response in inbred and outbred strains of mice to antigens unrelated to the yeast. Conditions which favor this event include the use of a particulate antigen, injection of antigen and fungus simultaneously, and injection of both substances i.p.
C. albicans cell walls and soluble extracts, Induction of inflammation in the peritoneal cavity correlated with a more rapid uptake by the liver of SE from the cavity ( Table 2 ). Several observations suggest that this correlation may be important. First, glycogen, which promoted inflammation and caused enhanced anti-SE responses, also promoted a more rapid uptake by the liver of SE from the peritoneal cavity (our unpublished data). Second, response to the protein antigen CGG was only marginally affected by C. albicans (Fig. 2) , but when CGG was presented as attached to HE the response was greatly enhanced by the yeast. It may be expected that free antigen given i.p. would be rapidly taken up by the liver in the absence of inflammation, but when attached to HE vascular absorption of antigen from the peritoneal cavity occurs more slowly. In support of this idea we found that, after an i.p. injection of free 5"Cr, liver uptake of the radionuclide occurred just as rapidly with or without C. albicans (unpublished data). Third, the effect of C. albicans on anti-SE responses was marginal when SE were administered i.v. Actually the magnitude of the immune response to an i.p. injection of a 1% suspension of SE and C. albicans approached that of an i.v. injection of SE alone ( Table 1) .
The mechanism by which antigen trapping by the liver may be translated into an immune response is unknown. Although it may be assumed that in our studies SE are taken up by Kupffer cells, the role of these macrophages in antigen-specific immune responses is controversial (23, 30) . Alternatively the increased rate of liver uptake may be a coincidental event, and the important effect of peritoneal inflammation is induction of some other activity such as alteration of lymphocyte trafficking (9) .
The effect of yeasts on enhancing resistance to diseases such as tumors and infectious agents may involve mechanisms either in addition to or other than those proposed here for enhanced antibody responses. Yeast cell walls and waterinsoluble polysaccharides have been shown to inhibit certain types of tumors in mice and rats (1, 6, 17, 31) , and a water-insoluble glucan from S. cerevisiae increases resistance in animals to certain bacterial and viral diseases (28) . In the latter study, resistance in some animals correlated with a glucan-induced increase in antibody titers to the infectious agent. However, the polysaccharide was effective when administered i.v. and before injection of the infectious agents.
In our studies it is interesting that animals infected with live yeasts several days before giving SE developed enhanced anti-SE responses (Fig. 1) . If C. albicans is capable of inducing heightened antibody responses to cell-associated antigens in general, it may be logical to ask whether animals infected with this fungus tend to develop antibodies against their own cellular antigens. Autoantibodies and endocrinopathies of one or more organs have been found associated with certain forms of human candidiasis such as chronic mucocutaneous candidiasis (7, 26) . In many instances it is not clear whether autoantibody formation and endocrine disorders precede candidiasis or develop as a consequence of the fungal disease. Although many workers who investigate fungus-host interactions have concentrated on the effect of the host on the fungal agent, it is clear that further work is needed in understanding how the fungus affects the host.
